TC BioPharm

TC BioPharm's mission is to develop and commercialize innovative cell-based products to treat diseases, improve patient health, and enhance quality of life.TC BioPharm is a clinical development company with a pipeline of cell-based products capable of treating a variety of diseases, including cancer and severe viral infections. TCB is currently conducting Phase II/III clinical trials for its lead product, ImmuniCell®, in patients with renal cell carcinoma, non-small cell lung cancer, and melanoma.